Premature PRV: US FDA Mistakenly Announces Voucher Award For Enzyvant Ahead Of Approval

 
• By Sue Sutter
  
Starter pistol
US FDA jumped the gun in announcing a voucher award for Enzyvant's still unapproved treatment for congenital athymia. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet